Jonathan Watanabe, [professor of clinical pharmacy at the University of California, Irvine School of Pharmacy & Pharmaceutical Science] said the study findings shed light on what medications need to be maintained in stock at hospitals as well as which ones need to be understood clinically. The speed of data on the safety and effectiveness of the therapeutics cuts both ways, he noted. “We have to adapt the mindset to ensure that quality evidence reaches the public more quickly, and health data that is more limited is clearly presented to the public with caveats,” Watanabe said.
Researchers seek to understand COVID-19 medication trends
Pharmacy Today, Aug. 1, 2021
August 1, 2021